Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Atangan A"'
Autor:
Lu, Shu-Chen, Chen, Michelle, Atangan, Larissa, Killion, Elizabeth A., Komorowski, Renee, Cheng, Yuan, Netirojjanakul, Chawita, Falsey, James R., Stolina, Marina, Dwyer, Denise, Hale, Clarence, Stanislaus, Shanaka, Hager, Todd, Thomas, Veena A., Harrold, John M., Lloyd, David J., Véniant, Murielle M.
Publikováno v:
In Cell Reports Medicine 18 May 2021 2(5)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elizabeth A. Killion, Michelle Chen, James R. Falsey, Glenn Sivits, Todd Hager, Larissa Atangan, Joan Helmering, Jae Lee, Hongyan Li, Bin Wu, Yuan Cheng, Murielle M. Véniant, David J. Lloyd
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Both agonism and antagonism of the glucose-dependent insulinotropic polypeptide receptor (GIPR) lead to weight loss in combination with glucagon-like peptide-1 receptor agonists in preclinical models. Here the authors show that this may be explained
Externí odkaz:
https://doaj.org/article/35bda07550384ea78b2522ff1a815550
Autor:
Shu-Chen Lu, Michelle Chen, Larissa Atangan, Elizabeth A. Killion, Renee Komorowski, Yuan Cheng, Chawita Netirojjanakul, James R. Falsey, Marina Stolina, Denise Dwyer, Clarence Hale, Shanaka Stanislaus, Todd Hager, Veena A. Thomas, John M. Harrold, David J. Lloyd, Murielle M. Véniant
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 5, Pp 100263- (2021)
Summary: Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) regulate glucose and energy homeostasis. Targeting both pathways with GIP receptor (GIPR) antagonist antibody (GIPR-Ab) and GLP-1 receptor (GLP-1R) agonis
Externí odkaz:
https://doaj.org/article/6fa1243f07684a9b91237d0446fb0986
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lu, Shu-Chen 1, *, Atangan, Larissa *, Won Kim, Ki *, Chen, Michelle M. *, Komorowski, Renee *, Chu, Carolyn †, Han, Joon †, Hu, Sylvia †, Gu, Wei *, Véniant, Murielle *, Wang, Minghan *
Publikováno v:
In Journal of Lipid Research April 2012 53(4):643-652
Autor:
Todd Hager, Jae Lee, Hongyan Li, David Lloyd, James R. Falsey, Elizabeth A. Killion, Bin Wu, Larissa Atangan, Yuan Cheng, Michelle Chen, Murielle M. Véniant, Joan Helmering, Glenn Sivits
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Nature Communications
Nature Communications
Antagonism or agonism of the glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) prevents weight gain and leads to dramatic weight loss in combination with glucagon-like peptide-1 receptor agonists in preclinical models. Based on the g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e345ea930fa8a2a065b4ce5c63e709e9
http://link.springer.com/article/10.1038/s41467-020-18751-8
http://link.springer.com/article/10.1038/s41467-020-18751-8
Autor:
Shu-Chen Lu, Larissa Atangan, Ki Won Kim, Michelle M. Chen, Renee Komorowski, Carolyn Chu, Joon Han, Sylvia Hu, Wei Gu, Murielle Véniant, Minghan Wang
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 4, Pp 643-652 (2012)
The aim of this study is to investigate the capability of an apoA-I mimetic with multiple amphipathic helices to form HDL-like particles in vitro and in vivo. To generate multivalent helices and to track the peptide mimetic, we have constructed a pep
Externí odkaz:
https://doaj.org/article/a775798b200f4d0c9d8610bf5f2ea9a3
Autor:
Qin, Suofu, Okawa, Yumiko, Atangan, Larissa I., Brown, Geoffrey, Chandraratna, Roshantha A., Zhao, Yi
Publikováno v:
In Journal of Steroid Biochemistry and Molecular Biology 2008 112(1):25-31
Autor:
Elizabeth A. Killion, Yuan Cheng, John M. Harrold, Veena A. Thomas, Shu-Chen Lu, James R. Falsey, Chawita Netirojjanakul, David Lloyd, Clarence Hale, Todd Hager, Shanaka Stanislaus, Marina Stolina, Renee Komorowski, Larissa Atangan, Murielle M. Véniant, Denise Dwyer, Michelle Chen
Publikováno v:
Cell Reports Medicine
Cell Reports Medicine, Vol 2, Iss 5, Pp 100263-(2021)
Cell Reports Medicine, Vol 2, Iss 5, Pp 100263-(2021)
Summary Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) regulate glucose and energy homeostasis. Targeting both pathways with GIP receptor (GIPR) antagonist antibody (GIPR-Ab) and GLP-1 receptor (GLP-1R) agonist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38ac5166f5323cefa07e391f43ee52d4
https://pubmed.ncbi.nlm.nih.gov/34095885
https://pubmed.ncbi.nlm.nih.gov/34095885